论著

322例河南省人类免疫缺陷病毒感染/获得性免疫缺陷综合征合并肺部感染患者的病原学特征分析

  • 王延丽 ,
  • 侯明杰 ,
  • 原海珍 ,
  • 辛宁波 ,
  • 张玉伟 ,
  • 韩磊 ,
  • 张一帆 ,
  • 马玉青 ,
  • 赵清霞
展开
  • 郑州大学附属传染病医院/郑州市第六人民医院感染一科,河南 郑州 450002
赵清霞 E-mail:Zhqx666@163.com

收稿日期: 2026-01-16

  修回日期: 2026-01-31

  录用日期: 2026-02-12

  网络出版日期: 2026-04-08

基金资助

2023年河南省重点研发与推广专项(科技攻关)(232102310014);郑州市医疗卫生领域科技创新指导项目(2024YLZDJH384);新发突发与重大传染病防控国家重大专项(2025ZD01905005);2024年河南省重点研发与推广专项(科技攻关)(242102310019)

版权

《内科理论与实践》编辑部, 2025, 版权所有,未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。

Analysis on etiological characteristics of 322 patients with human immunodeficiency virus infection / acquired immunodeficiency syndrome complicated with pulmonary infection in Henan province

  • WANG Yanli ,
  • HOU Mingjie ,
  • YUAN Haizhen ,
  • XIN Ningbo ,
  • ZHANG Yuwei ,
  • HAN Lei ,
  • ZHANG Yifan ,
  • MA Yuqing ,
  • ZHAO Qingxia
Expand
  • Department of Infectious Disease I, Affiliated Infectious Diseases Hospital of Zhengzhou University / the Sixth People’s Hospital of Zhengzhou, Zhengzhou 450002, China

Received date: 2026-01-16

  Revised date: 2026-01-31

  Accepted date: 2026-02-12

  Online published: 2026-04-08

Copyright

, 2025, Copyright reserved © 2025.

摘要

目的:探讨人类免疫缺陷病毒(human immunodeficiency virus, HIV)/获得性免疫缺陷综合征(acquired immunodeficiency syndrome,AIDS)患者(统称people living with HIV, PLWH)合并肺部感染的病原学特征,评估宏基因组二代测序(metagenomic next-generation sequencing, mNGS)技术在诊断中的价值。方法:回顾性纳入322例PLWH合并肺部感染患者,收集其临床资料与支气管肺泡灌洗液,分别进行传统病原学检测[涂片、培养、聚合酶链反应(polymerase chain reaction, PCR)]和mNGS检测,比较不同方法的病原体检出率、报告周期及检出病原学特征,并分析不同CD4+T淋巴细胞水平下的病原学变化。结果:322例患者中,男性占80.1%(258/322),中位年龄为35岁,CD4+T淋巴细胞中位数61(22,205)个/μL, HIV RNA 载量中位数1 343(0,159 423)拷贝/mL。mNGS成功检测294例,共检出病原体93种/786例次。病原体以病毒(34.4%,32种)为主,最常见为巨细胞病毒(cytomegalovirus, CMV)(44.7%)、耶氏肺孢子菌(40.4%)、EB病毒(14.6%)、结核分枝杆菌复合群(11.2%)、新型冠状病毒(9.0%)、黄曲霉/米曲霉(8.7%)。传统方法综合灵敏度为64.0%,mNGS为91.0%,差异具有统计学意义(P<0.001)。mNGS报告周期显著短于传统方法。CD4+T淋巴细胞<200个/μL的AIDS期患者病原体检出数量最多(648例次)。结论:PLWH合并肺部感染以CMV、耶氏肺孢子菌、结核分枝杆菌、新型冠状病毒及曲霉菌为主,不同免疫状态下感染的病原学种类不同,低CD4患者易受耶氏肺孢子菌、 CMV 等机会性病原体感染,随着CD4计数增加,病毒和真菌仍是主要的病原体类型,但细菌检出比例相对增加。mNGS可显著提高PLWH合并肺部感染患者的病原体检出率。

本文引用格式

王延丽 , 侯明杰 , 原海珍 , 辛宁波 , 张玉伟 , 韩磊 , 张一帆 , 马玉青 , 赵清霞 . 322例河南省人类免疫缺陷病毒感染/获得性免疫缺陷综合征合并肺部感染患者的病原学特征分析[J]. 内科理论与实践, 2026 , 21(01) : 21 -27 . DOI: 10.16138/j.1673-6087.2026.01.03

Abstract

Objective To discuss the etiological characteristics of patients with human immunodeficiency virus (HIV) / acquired immunodeficiency syndrome (AIDS) [collectively referred to as people living with HIV (PLWH)] complicated with pulmonary infection, and to evaluate the diagnostic value of metagenomic next-generation sequencing (mNGS) technology. Methods A retrospective study was conducted on 322 PLWH with pulmonary infection, whose clinical data and bronchoalveolar lavage fluid samples were collected. All samples underwent both conventional etiological tests [smear, culture, polymerase chain reaction (PCR)] and mNGS. The pathogen detection rates, reporting times, and detected etiological characteristics were compared between the two methods. Etiological variations under different CD4+ T lymphocyte levels were also analyzed. Results Among the 322 patients, 80.1% (258/322) were male, with a median age of 35 years. The median CD4+ T lymphocyte count was 61 (22, 205) cells/µL, and the median HIV RNA load was 1 343 (0, 159 423) copies/mL. mNGS was successfully performed on 294 patients, detecting a total of 93 pathogen species across 786 instances. Viruses were the predominant pathogens (34.4%, 32 species), with the most common being cytomegalovirus (CMV, 44.7%), Pneumocystis jirovecii (40.4%), Epstein-Barr virus (14.6%), Mycobacterium tuberculosis complex (11.2%), coronavirus disease 2019(COVID-19)(9.0%), and Aspergillus flavus/A. oryzae(8.7%). The overall sensitivity of conventional methods was 64%, with a statistically significant difference (P<0.001) compared to 91.0% for mNGS. The reporting time of mNGS was significantly shorter than of conventional methods. Patients at the AIDS stage, whose CD4+ T lymphocytes<200 cells/µL, had the highest total number of detected pathogens (648 instances). Conclusions Pulmonary infections in PLWH are primarily caused by CMV, P. jirovecii, M. tuberculosis complex, COVID-19, and Aspergillus species, with the etiological spectrum varying according to immune status. Patients with low CD4 counts are susceptible to opportunistic pathogens such as Pneumocystis jirovecii and CMV. As the CD4 count increases, viruses and fungi remain the predominant types of pathogens, but the proportion of bacterial detection relatively increases. mNGS can significantly improve the pathogen detection rate in PLWH with pulmonary infection.

参考文献

[1] GBD 2019 HIV Collaborators. Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990-2019, for 204 countries and territories[J]. Lancet HIV, 2021, 8(10):e633-e651.
[2] Li X, Liang S, Zhang D, et al. The clinical application of metagenomic next-generation sequencing in sepsis of immunocompromised patients[J]. Front Cell Infect Microbiol, 2023, 13:1170687.
[3] Guo C, Chen Q, Fan G, et al. gcPathogen: a comprehensive genomic resource of human pathogens for public health[J]. Nucleic Acids Res, 2024, 52(D1):D714-D723.
[4] 刘颖, 赵红心. 中国艾滋病相关机会性感染研究进展[J]. 中国艾滋病性病, 2022, 28(5):512-518.
  Liu Y, Zhao HX. Research progress in AIDS-related opportunistic infections in China[J]. Chin J AIDS STD, 2022, 28(5):512-518.
[5] 莫平征, 张忠威, 陈小平, 等. 宏基因组学二代测序在艾滋病合并肺部感染患者中的临床应用[J]. 中华传染病杂志, 2023, 41(8):507-513.
  Mo PZ, Zhang ZW, Chen XP, et al. Clinical application of metagenomic next-generation sequencing in acquired immunodeficiency syndrome patients with pulmonary infections[J]. Chin J Infect Dis, 2023, 41(8):507-513.
[6] World Health Organization. Global tuberculosis report 2025 [EB/OL]. 2025. https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2025.
[7] 曾妍茗, 李瑶, 刘敏, 等. 巨细胞病毒血症对艾滋病合并中重度肺孢子菌肺炎患者临床预后影响的回顾性研究[J]. 中国感染与化疗杂志, 2023, 23(2):137-142.
  Zeng YM, Li Y, Liu M, et al. Retrospective analysis of the effect of cytomegalovirus viremia on clinical prognosis of AIDS patients complicated with moderate to severe Pneumocystis pneumonia[J]. Chin J Infect Chemother, 2023, 23(2):137-142.
[8] 郭晶晶, 王雅杰, 方伟, 等. 艾滋病合并巨细胞病毒感染的病毒学和血清学特点探讨[J]. 标记免疫分析与临床, 2022, 29(12):1986-1989.
  Guo JJ, Wang YJ, Fang W, et al. The virology and serologic characteristics of HIV infection with cytomegalovirus[J]. Labeled Immunoassays & Clin Med, 2022, 29(12):1986-1989.
[9] Zhao M, Zhuo C, Li Q, et al. Cytomegalovirus (CMV) infection in HIV/AIDS patients and diagnostic values of CMV-DNA detection across different sample types[J]. Ann Palliat Med, 2020, 9(5):2710-2715.
[10] Kovacs JA, Gill VJ, Meshnick S, et al. New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia[J]. JAMA, 2001, 286(19):2450-2460.
[11] Gérard L, Leport C, Flandre P, et al. Cytomegalovirus (CMV) viremia and the CD4+ lymphocyte count as predictors of CMV disease in patients infected with human immunodeficiency virus[J]. Clin Infect Dis, 1997, 24(5):836-840.
[12] 中华医学会感染病学分会艾滋病丙型肝炎学组. 艾滋病合并巨细胞病毒病诊疗专家共识(2024年版)[J]. 中华传染病杂志, 2024, 42(3):129-140.
  AIDS and Hepatitis C Professional Group of Society of Infectious Diseases of Chinese Medical Association. Expert consensus on diagnosis and treatment of cytomegalovirus disease in acquired immunodeficiency syndrome patients in China (2024 edition)[J]. Chin J Infect Dis, 2024, 42(3):129-140.
[13] 陈娜, 邓美菊, 刘颖, 等. 152例艾滋病合并肺部感染疾病谱分析[J]. 国际病毒学杂志, 2024, 31(3):211-214.
  Chen N, Deng MJ, Liu Y, et al. Spectrum of complicated pulmonary infections in 152 AIDS patients[J]. International Journal of Virology, 2024, 31(3):211-214.
[14] Patel EU, Gianella S, Newell K, et al. Elevated cytomegalovirus IgG antibody levels are associated with HIV-1 disease progression and immune activation[J]. AIDS, 2017, 31(6):807-813.
[15] Perello R, Vergara A, Monclus E, et al. Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy[J]. BMC Infect Dis, 2019, 19(1):1030.
[16] 任立敏, 李妍, 张春芳, 等. 系统性风湿病合并巨细胞病毒感染的临床特点及其相关危险因素分析[J]. 中华医学杂志, 2016, 96(35):2772-2776.
  Ren LM, Li Y, Zhang CF, et al. Clinical characteristics and associated risk factors of cytomegalovirus infection in patients with underlying systemic rheumatic diseases[J]. Natl Med J China, 2016, 96(35):2772-2776.
[17] 宋聪, 余小舒, 周昌静, 等. 艾滋病合并耶氏肺孢子菌肺炎患者巨细胞病毒活动情况的影响因素[J]. 名医, 2025(9):51-53.
  Song C, Yu XS, Zhou CJ, et al. Factors influencing cytomegalovirus activity in AIDS patients with Pneumocystis jirovecii pneumonia[J]. Renowned Doctor, 2025(9):51-53.
[18] Grabar S, Le Moing V, Goujard C, et al. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy[J]. Ann Intern Med, 2000, 133(6):401-410.
[19] Affandi JS, Montgomery J, Brunt SJ, et al. The immunological footprint of CMV in HIV-1 patients stable on long-term ART[J]. Immun Ageing, 2015, 12:14.
[20] Tan Y, Chen Z, Zeng Z, et al. Microbiomes detected by bronchoalveolar lavage fluid metagenomic next-generation sequencing among HIV-infected and uninfected patients with pulmonary infection[J]. Microbiol Spectr, 2023, 11(4):e0000523.
[21] Fan Q, Tang G, Jiang M, et al. Clinical prognostic value of TTV and HCMV but not EBV for outcomes in hospitalized HIV-positive patients[J]. Biosaf Health, 2025, 7(3):173-182.
[22] 中华医学会热带病与寄生虫学分会艾滋病学组. 人类免疫缺陷病毒/艾滋病患者合并非结核分枝杆菌感染诊治专家共识[J]. 中华传染病杂志, 2019, 37(3):129-138.
  AIDS Professional Group of Society of Tropical Disease and Parasitology of Chinese Medical Association. Expert consensus on diagnosis and treatment of HIV/AIDS complicated with non-tuberculous mycobacteria infection[J]. Chin J Infect Dis, 2019, 37(3):129-138.
[23] 张沛, 赵阿会, 高敏, 等. 2016-2021年河南省MTB/HIV双重感染流行特征分析[J]. 中国防痨杂志, 2023, 45(4): 377-382.
  Zhang P, Zhao AH, Gao M, et al. Epidemiological characteristics of MTB/HIV co-infection in Henan from 2016 to 2021[J]. Chin J Antitubercul, 2023, 45(4):377-382.
[24] Geldmacher C, Ngwenyama N, Schuetz A, et al. Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4+ T cells after HIV-1 infection[J]. J Exp Med, 2010, 207(13):2869-2881.
[25] Bertagnolio S, Thwin SS, Silva R, et al. Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19[J]. Lancet HIV, 2022, 9(7):e486-e495.
[26] Parize P, Muth E, Richaud C, et al. Untargeted next-generation sequencing-based first-line diagnosis of infection in immunocompromised adults: a multicentre, blinded, prospective study[J]. Clin Microbiol Infect, 2017, 23(8):574..
文章导航

/